Seegene, Inc. (096530.KQ)
KRW 23550.0
(-1.26%)
KRW 23550.0
(-1.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -48.57 Billion KRW | 86.59% |
| 2022 | -362.16 Billion KRW | -32.63% |
| 2021 | -273.06 Billion KRW | -33.15% |
| 2020 | -205.08 Billion KRW | -503.23% |
| 2019 | -33.99 Billion KRW | -52.09% |
| 2018 | -22.35 Billion KRW | -178.97% |
| 2017 | -8.01 Billion KRW | -8751.96% |
| 2016 | 92.61 Million KRW | -99.14% |
| 2015 | 10.82 Billion KRW | -3.1% |
| 2014 | 11.16 Billion KRW | 68.63% |
| 2013 | 6.62 Billion KRW | 253.78% |
| 2012 | -4.3 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -76.25 Billion KRW | -67.17% |
| 2024 Q1 | -45.61 Billion KRW | 6.09% |
| 2023 Q2 | 14.75 Billion KRW | 112.51% |
| 2023 Q4 | -48.57 Billion KRW | -34.99% |
| 2023 FY | -48.57 Billion KRW | 86.59% |
| 2023 Q1 | -117.92 Billion KRW | 67.44% |
| 2023 Q3 | -35.98 Billion KRW | -343.9% |
| 2022 Q4 | -362.16 Billion KRW | -969.73% |
| 2022 Q3 | -33.85 Billion KRW | 88.82% |
| 2022 Q2 | -302.81 Billion KRW | 27.81% |
| 2022 Q1 | -419.47 Billion KRW | -53.62% |
| 2022 FY | -362.16 Billion KRW | -32.63% |
| 2021 Q1 | -205.9 Billion KRW | 2.71% |
| 2021 Q4 | -273.06 Billion KRW | -0.29% |
| 2021 Q3 | -272.28 Billion KRW | -79.58% |
| 2021 FY | -273.06 Billion KRW | -33.15% |
| 2021 Q2 | -151.62 Billion KRW | 26.36% |
| 2020 Q3 | -107.3 Billion KRW | -7.24% |
| 2020 FY | -205.08 Billion KRW | -503.23% |
| 2020 Q1 | -38.68 Billion KRW | -6.26% |
| 2020 Q2 | -100.05 Billion KRW | -158.66% |
| 2020 Q4 | -211.62 Billion KRW | -97.22% |
| 2019 Q1 | -25.38 Billion KRW | -13.57% |
| 2019 FY | -33.99 Billion KRW | -52.09% |
| 2019 Q3 | -36.05 Billion KRW | -11.7% |
| 2019 Q2 | -32.28 Billion KRW | -27.17% |
| 2019 Q4 | -36.4 Billion KRW | -0.96% |
| 2018 Q3 | -20.84 Billion KRW | -19.22% |
| 2018 Q2 | -17.48 Billion KRW | -4.87% |
| 2018 Q1 | -16.67 Billion KRW | -108.07% |
| 2018 FY | -22.35 Billion KRW | -178.97% |
| 2018 Q4 | -22.35 Billion KRW | -7.24% |
| 2017 Q4 | -8.01 Billion KRW | -6.24% |
| 2017 Q2 | 831.27 Million KRW | 130.44% |
| 2017 FY | -8.01 Billion KRW | -8751.96% |
| 2017 Q1 | -2.73 Billion KRW | -3049.13% |
| 2017 Q3 | -7.54 Billion KRW | -1007.3% |
| 2016 FY | 92.61 Million KRW | -99.14% |
| 2016 Q3 | -1.09 Billion KRW | -124.29% |
| 2016 Q1 | 5.94 Billion KRW | 19.87% |
| 2016 Q2 | 4.5 Billion KRW | -24.14% |
| 2016 Q4 | 92.61 Million KRW | 108.45% |
| 2015 Q2 | -911.04 Million KRW | -107.24% |
| 2015 FY | 10.82 Billion KRW | -3.1% |
| 2015 Q4 | 4.95 Billion KRW | 360.86% |
| 2015 Q3 | -1.9 Billion KRW | -108.67% |
| 2015 Q1 | 12.58 Billion KRW | 12.74% |
| 2014 Q4 | 11.16 Billion KRW | -38.0% |
| 2014 Q3 | 18.01 Billion KRW | 5.45% |
| 2014 Q2 | 17.08 Billion KRW | 3.86% |
| 2014 Q1 | 16.44 Billion KRW | 148.35% |
| 2014 FY | 11.16 Billion KRW | 68.63% |
| 2013 FY | 6.62 Billion KRW | 253.78% |
| 2013 Q3 | 22.49 Billion KRW | -5.81% |
| 2013 Q4 | 6.62 Billion KRW | -70.57% |
| 2013 Q1 | 28.53 Billion KRW | 762.77% |
| 2013 Q2 | 23.88 Billion KRW | -16.31% |
| 2012 FY | -4.3 Billion KRW | 0.0% |
| 2012 Q4 | -4.3 Billion KRW | -5.06% |
| 2012 Q3 | -4.09 Billion KRW | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | -108.91 Billion KRW | 55.4% |
| InBody Co.,Ltd | -16.2 Billion KRW | -199.753% |
| Curexo Inc. | -15.03 Billion KRW | -223.146% |
| i-SENS, Inc. | 98.45 Billion KRW | 149.339% |
| Ray Co., Ltd. | 67.09 Billion KRW | 172.401% |
| Gencurix Inc. | 15.02 Billion KRW | 423.304% |
| Sugentech Inc. | -6.95 Billion KRW | -598.803% |
| L&C Bio Co., Ltd | 67.18 Billion KRW | 172.304% |